Galectin‐3 as a biomarker in breast neoplasms: Mechanisms and applications in patient care
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Leukocyte Biology"
DOI: 10.1002/jlb.5mr0822-673r
Abstract: Galectin‐3 is a member of the lectin family encoded by the LGALS3 gene on chromosome 14. It is secreted by a wide range of immune cells and mammary tumor cells. Through its activity on the… read more here.
Keywords: biomarker; breast; tumor microenvironment; breast neoplasms ... See more keywords
Update on selective special types of breast neoplasms: Focusing on controversies, differential diagnosis, and molecular genetic advances.
Sign Up to like & getrecommendations! Published in 2022 at "Seminars in diagnostic pathology"
DOI: 10.1053/j.semdp.2022.03.001
Abstract: Classification of breast tumors has been evolving in the last decade. Uncommon types of breast neoplasms have been increasingly recognized. While the pathogenesis of a subset of these tumors remains to be ascertained, integration of… read more here.
Keywords: types breast; selective special; molecular genetic; breast neoplasms ... See more keywords
Assessing the causality between thyroid and breast neoplasms: A bidirectional Mendelian randomization study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.973161
Abstract: Aim This study aimed to evaluate the association between thyroid neoplasms (TN) and the risk of developing breast neoplasms (BN) by assessing data on single nucleotide polymorphisms (SNPs) obtained from the Deutsches Krebsforschungszentrum (DKFZ) and… read more here.
Keywords: mendelian randomization; breast; breast neoplasms; association ... See more keywords